Lyase to live by: Sphingosine phosphate lyase as a therapeutic target
- 17 June 2009
- journal article
- review article
- Published by Informa UK Limited in Emerging Therapeutic Targets
- Vol. 13 (8), 1013-1025
- https://doi.org/10.1517/14728220903039722
Abstract
Background: Sphingosine 1-phosphate (S1P) is a bioactive lipid that regulates cell proliferation, survival and migration and plays an essential role in angiogenesis and lymphocyte trafficking. S1P levels in the circulation and tissues are tightly regulated for proper cell functioning, and dysregulation of this system may contribute to the pathophysiology of certain human diseases. Sphingosine phosphate lyase (SPL) irreversibly degrades S1P and thereby acts as a gatekeeper that regulates S1P signaling by modulating intracellular S1P levels and the chemical S1P gradient that exists between lymphoid organs and circulating blood and lymph. However, SPL also generates biochemical products that may be relevant in human disease. SPL has been directly implicated in various physiological and pathological processes, including cell stress responses, cancer, immunity, hematopoietic function, muscle homeostasis, inflammation and development. Objective/methods: This review summarizes the current know-ledge of SPL structure, function and regulation, its involvement in various disease states and currently available small molecules known to modulate SPL activity. Results/conclusion: This review provides evidence that SPL is a potential target for pharmacological manipulation for the treatment of malignant, autoimmune, inflammatory and other diseases.Keywords
This publication has 114 references indexed in Scilit:
- Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient NeuronsPublished by Elsevier BV ,2009
- The alliance of sphingosine-1-phosphate and its receptors in immunityNature Reviews Immunology, 2008
- Sphingosine-1-phosphate lyase in development and disease: Sphingolipid metabolism takes flightBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- Deregulation of sphingolipid metabolism in Alzheimer's diseaseNeurobiology of Aging, 2008
- Roles of Bioactive Sphingolipids in Cancer Biology and TherapeuticsSubcellular Biochemistry, 2007
- An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Disruption of sphingolipid metabolism elicits apoptosis-associated reproductive defects in DrosophilaDevelopmental Biology, 2007
- Redirection of sphingolipid metabolism toward de novo synthesis of ethanolamine in LeishmaniaThe EMBO Journal, 2007
- Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is down-regulated in colon cancerProceedings of the National Academy of Sciences of the United States of America, 2006
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002